OPTHEA LIMITED news, videos and press releases - Page 2
For more news please use our advanced search feature.
OPTHEA LIMITED - More news...
OPTHEA LIMITED - More news...
- Opthea A$55.0m (US$36.9m¹) Retail Entitlement Offer Opens
- Opthea Successfully Completes Placement and Institutional Component of Entitlement Offer Raising A$171.5 million (US$113.2m¹)
- Opthea Announces Placement and Partially Underwritten Entitlement Offer to Raise up to Approximately A$227.3 million (US$150.0 million¹)
- Opthea To Present at Clinical Trials at the Summit Meeting
- Opthea Completes Enrollment in Pivotal Phase 3 Clinical Program with Sozinibercept in Wet AMD
- Opthea Announces Upcoming Presentations at the Retina World Congress 2024
- Opthea to Present at the OIS Retina Innovation Summit at ARVO
- Opthea Appoints John Han, PharmD, as VP Medical Affairs
- Opthea to Participate in the 23ʳᵈ Annual Needham Virtual Healthcare Conference
- Opthea Appoints Sujal Shah to the Board of Directors
- Opthea to Host Key Opinion Leader Event on Sozinibercept (OPT-302) in Wet Age-Related Macular Degeneration on April 3, 2024
- Opthea to Participate in the Leerink Partners Global Biopharma Conference
- Opthea Reports Half-Year Financial Results and Business Updates
- Opthea Appoints Arshad M. Khanani, MD, MA, FASRS, as Chief Medical Advisor
- Opthea Completes Enrollment in First Pivotal Trial with Sozinibercept
- Opthea Strengthens Team with Key Clinical and Regulatory Hires
- Opthea to Receive US$35M Commitment and Additional US$50M Funding
- Opthea Receives A$8.8 million R&D Tax Incentive
- Opthea to Present at the FLORetina 2023 Congress
- Opthea to Present at the Jefferies 2023 London Healthcare Conference
- Opthea to Present at Eyecelerator Forum at the 2023 American Academy of Ophthalmology (AAO) Conference
- Opthea Appoints U.S.-Based Leadership with Fred Guerard as CEO and Peter Lang as CFO
